← Open Payments lookup

AMANDA GANT: Open Payments

NPI 1972216273 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$374 in 19 payments from 11 companies in 2025. Trend: 2023 $830 · 2024 $1,072 · 2025 $374

Food & beverage: $374
CompanyPaymentsAmount
ABBVIE INC.4$71
Supernus Pharmaceuticals, Inc.4$67
Otsuka America Pharmaceutical, Inc.2$48
Teva Pharmaceuticals USA, Inc.2$45
Axsome Therapeutics, Inc.1$31
Almatica Pharma LLC1$22
Indivior Inc.1$20
E.R. Squibb & Sons, L.L.C.1$19
Neurocrine BioSciences, Inc.1$19
Vanda Pharmaceuticals Inc.1$17

Products named: VRAYLAR, Qelbree, AUSTEDO XR, Auvelity, ABILIFY MAINTENA, LOREEV XR, REXULTI, SUBLOCADE.

Industry payments across NV — which companies pay providers there.